Advanced Filter

Filter by Group

Filter by Market Availability

Displaying 1 drug
Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood used as an allogeneic stem cell donor source. Umbilical blood cord cells are expanded ex-vivo and nicotinamide (a form of vitamin B3) is used as an active agent in the culture system to inhibit the differentiation and...
Approved
Investigational
Matched Synonyms: … fraction (CF) ... Omidubicel ... Omidubicel-onlv …
Matched Name: … Omidubicel
Matched Description: … [A258958] In April 2023, the FDA approved the use of omidubicel in adults and pediatric patients 12 years ... In addition, the fact that 39% of the study's cohort were non-White patients highlights the importance ... Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord …
Matched Categories: … Cells, Cultured, Allogeneic …
Displaying 1 drug